{"keywords":["gastric cancer","trastuzumab"],"genes":["human epidermal growth factor receptor 2","HER2"],"organisms":["9606"],"publicationTypes":["Journal Article"],"abstract":"Gastric cancer remains difficult to cure and has a poor overall prognosis. Chemotherapy and multimodality therapy has shown some benefit in the treatment of gastric cancer. Current therapies for gastric cancer have their limitations; thus, we are in need of newer treatment options including targeted therapies. Here, we review the biologic therapy with trastuzumab in human epidermal growth factor receptor 2 (HER2)+ gastric cancer.","title":"Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.","pubmedId":"23450234"}